Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes

AIMS: To simplify administration of aqueous exenatide once weekly, which requires reconstitution, the exenatide microspheres have been reformulated in a ready‐to‐use autoinjector with a Miglyol diluent (exenatide QWS‐AI). This study compared the efficacy and safety of exenatide QWS‐AI with the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Wysham, Carol H., Rosenstock, Julio, Vetter, Marion L., Dong, Fang, Öhman, Peter, Iqbal, Nayyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724491/
https://www.ncbi.nlm.nih.gov/pubmed/28685973
http://dx.doi.org/10.1111/dom.13056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724491/
https://www.ncbi.nlm.nih.gov/pubmed/28685973
http://dx.doi.org/10.1111/dom.13056

Ejemplares similares